
AstraZeneca-Daiichi Sankyo Datroway gets USFDA accelerated nod for previously treated advanced EGFR-mutated non-small ...
Cambridge: AstraZeneca and Daiichi Sankyo have announced that Datroway (datopotamab deruxtecan or Dato-DXd) has received accelerated approval from the Food and Drug Administration (FDA) for the treatment of adult patients with locally advanced or …